ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OVID Ovid Therapeutics Inc

3.10
0.11 (3.68%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 80,529
Bid Price 2.95
Ask Price 3.23
News -
Day High 3.13

Low
2.57

52 Week Range

High
4.1389

Day Low 2.99
Share Name Share Symbol Market Stock Type
Ovid Therapeutics Inc OVID NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.11 3.68% 3.10 18:17:52
Open Price Low Price High Price Close Price Previous Close
2.99 2.99 3.13 3.10 2.99
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
646 80,529 US$ 3.05 US$ 245,622 - 2.57 - 4.1389
Last Trade Type Quantity Price Currency
18:03:22 10 US$ 3.23 USD

Ovid Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
219.2M 70.71M - 392k -52.34M -0.74 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Ovid Therapeutics News

Date Time Source News Article
4/04/202407:00GlobeNewswire Inc.Ovid Therapeutics to Present at the 23rd Annual Needham..
3/08/202407:24Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/08/202407:20Edgar (US Regulatory)Form 8-K - Current report
3/08/202407:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates, Fourth Quarter..
2/28/202407:00GlobeNewswire Inc.Ovid Therapeutics to Present at the TD Cowen 44th Annual..
2/26/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/14/202410:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202405:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OVID Message Board. Create One! See More Posts on OVID Message Board See More Message Board Posts

Historical OVID Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.193.292.993.15143,681-0.09-2.82%
1 Month3.083.352.993.16137,9350.020.65%
3 Months3.814.102.603.15211,065-0.71-18.64%
6 Months3.504.102.573.25173,421-0.40-11.43%
1 Year3.044.13892.573.47200,2400.061.97%
3 Years3.674.801.4053.37224,304-0.57-15.53%
5 Years1.9510.451.4053.97653,4121.1558.97%

Ovid Therapeutics Description

Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life.

Your Recent History

Delayed Upgrade Clock